TerminatedNot Applicable

Post-market Study of the Biodesign Hernia Graft

Stopped: Business decision

United States, Canada74 participantsStarted 2020-11-10

Plain-language summary

The purpose of this study is to collect data on the performance of the Biodesign® Hernia Graft when used to reinforce soft tissues during ventral hernia repair.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Known sensitivity to porcine material
✕. Age \< 18 years
✕. Unable or unwilling to provide informed consent
✕. Life expectancy of less than one year from the date of the index procedure
✕. Patients will be excluded from the study if they never receive a Biodesign Hernia Graft during their index procedure.

What they're measuring

Hernia Recurrence

Timeframe: 1-year

Trial details

NCT IDNCT04294446

SponsorCook Biotech Incorporated

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-11-26

Results submitted2026-02-03

View on ClinicalTrials.gov More Ventral Hernia trials